Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Brazil / NCT07794267
Starting soon Observational

Remote Assessment of Pain and Recovery Quality After Surgery Using a Digital Form: A Pilot Study

NCT07794267 · tracked via the Priya Life Science Brazil tracker
Phase
Observational
Started
2026-10-01
Last updated
2026-08-31

Condition(s) studied

Remote Monitoring of Pain and Recovery Quality in the Immediate Postoperative Period Using a Digital Health ToolPain, PostoperativePostoperative Nausea and VomitingRecovery of Function (G11.427.698.620)

Investigational drug(s) / intervention(s)

Digital web-based postoperative follow-up form

Digital web-based postoperative follow-up form: A responsive, 18-item online questionnaire, accessed via a WhatsApp link, used to remotely collect patient-reported data on pain, nausea/vomiting, medication use, functional recovery, and satisfaction at 12 and 24 hours after PACU discharge. This is a data-collection tool and does not constitute a clinical/therapeutic intervention.

Study summary

After surgery, doctors need to know how patients are doing, especially in the first hours after they leave the recovery room. This can be hard to track once patients go to a regular hospital room, and some symptoms - like pain or nausea - may go unnoticed.

This study tests whether an online form, sent to patients' phones, can help doctors check on pain and recovery in the first 12 and 24 hours after surgery. Patients (or a family member helping them) will receive a link by WhatsApp and answer a short set of questions about their pain, nausea, medications, and how they are recovering.

The main goal is to find out whether patients are willing and able to use this online form, and whether it is a helpful and practical way to follow up with them after surgery.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age ≥ 18 years * Undergoing elective surgery with anticipated discharge from the post-anesthesia care unit (PACU) to the ward * Access to a smartphone with internet connection (personally, or through an accompanying caregiver) * Cognitive capacity to respond to the digital form, or availability of a caregiver to respond on the patient's behalf * Signed Informed Consent Form Exclusion Criteria: * Anticipated postoperative admission to the intensive care unit (ICU) * Inability to communicate, with no caregiver available to assist * Refusal to participate or to use the digital tool * No access to a mobile device/internet during the first 24 postoperative hours, with no logistical alternative available * Clinical condition that, at the discretion of the assisting team, contraindicates participation

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Hospital de Base do Distrito Federal (Instituto de Gestão Estratégica de Saúde do Distrito Federal - IGESDF) Brasília Federal District

More Hospital de Base trials in Brazil

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07794267 on ClinicalTrials.gov ↗ ← All trials in Brazil